Comparative efficacy and safety of probiotics for the treatment of irritable bowel syndrome: a systematic review and network meta-analysis protocol

INTRODUCTION: Irritable bowel syndrome (IBS) is a common chronic functional gastrointestinal disorder affecting approximately 10% to 25% of the adult population. A large number of clinical trials have been conducted to evaluate the efficacy of probiotics for IBS but the results were inconsistent. Pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Man, Yu, Yuanyuan, Lei, Ping-Guang, Yuan, Jinqiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Gastroenterology and Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003387/
https://www.ncbi.nlm.nih.gov/pubmed/31796470
http://dx.doi.org/10.1136/bmjopen-2018-027376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003387/
https://www.ncbi.nlm.nih.gov/pubmed/31796470
http://dx.doi.org/10.1136/bmjopen-2018-027376

Ejemplares similares